Literature DB >> 17494846

Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors.

Thomas K Rhee1, Joseph Y Young, Andrew C Larson, G Kenneth Haines, Kent T Sato, Riad Salem, Mary F Mulcahy, Laura M Kulik, Tatjana Paunesku, Gayle E Woloschak, Reed A Omary.   

Abstract

PURPOSE: To test the hypothesis that transcatheter arterial embolization (TAE) of VX2 rabbit liver tumors increases the expression of hypoxia-inducible factor-1alpha (HIF-1alpha), a transcription factor that regulates the expression of pro-angiogenic genes.
MATERIALS AND METHODS: VX2 tumors were implanted in the livers of eight New Zealand white rabbits. Once tumor growth was seen at T2-weighted turbo spin-echo magnetic resonance (MR) imaging, four of the eight rabbits underwent TAE with 45-150-mum polyvinyl alcohol particles. The remaining four rabbits served as non-TAE controls. The TAE end point was stasis of antegrade blood flow. All rabbits were sacrificed for tumor harvest 2 hours after TAE. Tumor tissue and corresponding normal liver tissue in each rabbit liver were stained with anti-human HIF-1alpha monoclonal antibody and reviewed with light microscopy. Percentages of stained viable tumor and normal liver cells were compared by using the Mann-Whitney U test (alpha=0.05).
RESULTS: In eight rabbits with 24 discrete liver tumors, the mean percentage (+/-standard deviation) of positive HIF-1alpha-stained cells in the TAE group was greater than that in the control group (19%+/-7.0 vs 12%+/-8.0, respectively) (P=.05). Normal liver tissue in both the TAE and control groups showed no HIF-1alpha staining.
CONCLUSION: Although HIF-1alpha is not expressed in normal rabbit liver parenchyma-even after TAE-HIF-1alpha expression is present in implanted VX2 rabbit liver tumors and significantly increased in lesions that have undergone embolization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494846     DOI: 10.1016/j.jvir.2007.02.031

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  24 in total

Review 1.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

2.  Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

Authors:  Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  ACS Nano       Date:  2013-08-20       Impact factor: 15.881

3.  Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.

Authors:  Weiguang Xu; Jung-Hee Kwon; Young Ho Moon; Young Bae Kim; Yun Suk Yu; Namgyu Lee; Kwan Yong Choi; Yun Soo Kim; Yong Keun Park; Bong Wan Kim; Hee Jung Wang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-23       Impact factor: 4.553

4.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

5.  Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.

Authors:  Dingxin Wang; Ron C Gaba; Brian Jin; Ahsun Riaz; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Ann B Ragin; Laura M Kulik; Mary F Mulcahy; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  Acad Radiol       Date:  2011-07       Impact factor: 3.173

Review 6.  Transcatheter intraarterial therapies: rationale and overview.

Authors:  Robert J Lewandowski; Jean-Francois Geschwind; Eleni Liapi; Riad Salem
Journal:  Radiology       Date:  2011-06       Impact factor: 11.105

7.  Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.

Authors:  Brian Jin; Dingxin Wang; Robert J Lewandowski; Ahsun Riaz; Robert K Ryu; Kent T Sato; Andrew C Larson; Riad Salem; Reed A Omary
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

8.  Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.

Authors:  Pi-Yi Chang; Chun-Chieh Huang; Chao-Hung Hung; Chih-Yung Yu; Ding-Kwo Wu; Jen-I Hwang; Po-Chin Liang; Reng-Hong Wu; Wei-Lun Tsai; Yih-Jyh Lin; Yi-Sheng Liu; Huei-Lung Liang; Rheun-Chuan Lee; Chien-Hung Chen
Journal:  Liver Cancer       Date:  2018-03-29       Impact factor: 11.740

9.  Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.

Authors:  Ron C Gaba; Dingxin Wang; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Laura M Kulik; Mary F Mulcahy; Andrew C Larson; Riad Salem; Reed A Omary
Journal:  J Vasc Interv Radiol       Date:  2008-09-25       Impact factor: 3.464

10.  Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.

Authors:  Thomas Josef Vogl; Jun Qian; Andreas Tran; Elsie Oppermann; Nagy N Naguib; Huedayi Korkusuz; Nour Eldin A Nour Eldin; Wolf Otto Bechstein
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.